As reported in a research article out of 110 patient had pfo closure using either cardioseal occluder, an amplatzer pfo occluder, an amplatzer septal occluder, or an amplatzer cribriform one patient had a device embolize, and four had a shunt requiring reoperation.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
Reference manufacturing report 2135147-2020-00078.It was reported through a research article identifying amplatzer devices that may be related to a complications post procedure.Details are listed in the article, titled "effect of residual interatrial shunt on migraine burden after transcatheter closure of patent foramen ovale." it was reported in the article that 110 patients underwent pfo closure using either: cardioseal occluder device, or any of the amplatzer pfo occluder, septal occluder, or cribiform devices.The average age of the patients was 42.7 years, with 74 of them being female.The comorbidities include: hypertension, diabetes, hypercoagulability, history of smoking, arrhythmias, and migraines.Post procedural complications includes: device embolization (1), reoperation due to shunt (4).
|